|
1
|
Ilson DH: Oesophageal cancer: new
developments in systemic therapy. Cancer Treat Rev. 29:525–532.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ellis V and Murphy G: Cellular strategies
for proteolytic targeting during migration and invasion. FEBS Lett.
506:1–5. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
4
|
Poincloux R, Lizárraga F and Chavrier P:
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to
invadopodia. J Cell Sci. 122:3015–3024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen WT and Kelly T: Seprase complexes in
cellular invasiveness. Cancer Metastasis Rev. 22:259–269. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelly T: Fibroblast activation protein-α
and dipeptidyl peptidase IV (CD26): cell-surface proteases that
activate cell signaling and are potential targets for cancer
therapy. Drug Resist Updat. 8:51–58. 2005.
|
|
7
|
O’Brien P and O’Connor BF: Seprase: an
overview of an important matrix serine protease. Biochim Biophys
Acta. 1784:1130–1145. 2008.PubMed/NCBI
|
|
8
|
Boonacker E and Van Noorden CJ: The
multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell
Biol. 82:53–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baum O, Reutter W and Bermpohl F:
Structure-function relationship of DPP IV: insights into its
dimerisation and gelatinase activity. Adv Exp Med Biol. 524:19–27.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Itoh Y: MT1-MMP: a key regulator of cell
migration in tissue. IUBMB Life. 58:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murphy G, Stanton H, Cowell S, et al:
Mechanisms for pro matrix metalloproteinase activation. APMIS.
107:38–44. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Toth M, Chvyrkova I, Bernardo MM, et al:
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of
TIMP-2 and plasma membranes. Biochem Biophys Res Commun.
308:386–395. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Levi E, Fridman R, Miao HQ, et al: Matrix
metalloproteinase 2 releases active soluble ectodomain of
fibroblast growth factor receptor 1. Proc Natl Acad Sci USA.
93:7069–7074. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Monsky WL, Kelly T, Lin CY, et al: Binding
and localization of Mr 72,000 matrix metalloproteinase
at cell surface invadopodia. Cancer Res. 53:3159–3164.
1993.PubMed/NCBI
|
|
16
|
Etoh T, Inoue H, Yoshikawa Y, et al:
Increased expression of collagenase-3 (MMP-13) and MT1-MMP in
oesophageal cancer is related to cancer aggressiveness. Gut.
47:50–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roh MR, Zheng Z, Kim HS, et al:
Differential expression patterns of MMPs and their role in the
invasion of epithelial premalignant tumors and invasive cutaneous
squamous cell carcinoma. Exp Mol Pathol. 92:236–242. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kajiyama H, Kikkawa F, Khin E, et al:
Dipeptidyl peptidase IV overexpression induces up-regulation of
E-cadherin and tissue inhibitors of matrix metalloproteinases,
resulting in decreased invasive potential in ovarian carcinoma
cells. Cancer Res. 63:2278–2283. 2003.
|
|
19
|
Kikkawa F, Kajiyama H, Shibata K, et al:
Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta.
1751:45–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kotani T, Aratake Y, Ogata Y, et al:
Expression of dipeptidyl aminopeptidase IV activity in thyroid
carcinoma. Cancer Lett. 57:203–208. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilson MJ, Ruhland AR, Quast BJ, et al:
Dipeptidylpeptidase IV activities are elevated in prostate cancers
and adjacent benign hyperplastic glands. J Androl. 21:220–226.
2000.PubMed/NCBI
|
|
22
|
Goscinski MA, Suo ZH, Nesland JM, et al:
Dipeptidyl peptidase IV expression in cancer and stromal cells of
human esophageal squamous cell carcinomas, adenocarcinomas and
squamous cell carcinoma cell lines. APMIS. 116:823–831. 2008.
View Article : Google Scholar
|
|
23
|
Mentlein R, Hattermann K, Hemion C, et al:
Expression and role of the cell surface protease seprase/fibroblast
activation protein-α (FAP-α) in astroglial tumors. Biol Chem.
392:199–207. 2011.PubMed/NCBI
|
|
24
|
Goscinski MA, Suo ZH, Nesland JM, et al:
Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen
activator expression in dysplasia and invasive squamous cell
carcinoma of the esophagus. A study of 229 cases from Anyang Tumor
Hospital, Henan Province, China. Oncology. 75:49–59. 2008.
View Article : Google Scholar
|
|
25
|
Yamashita M, Ogawa T, Zhang X, et al: Role
of stromal myofibroblasts in invasive breast cancer: stromal
expression of alpha-smooth muscle actin correlates with worse
clinical outcome. Breast Cancer. 19:170–176. 2012. View Article : Google Scholar
|
|
26
|
Jiang WG, Davies G, Martin TA, et al:
Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in
human breast cancer and its impact on invasiveness of breast cancer
cells. Int J Mol Med. 17:583–590. 2006.PubMed/NCBI
|
|
27
|
Adley BP, Gleason KJ, Yang XJ and Stack
MS: Expression of membrane type 1 matrix metalloproteinase (MMP-14)
in epithelial ovarian cancer: high level expression in clear cell
carcinoma. Gynecol Oncol. 112:319–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ueda J, Kajita M, Suenaga N, et al:
Sequence-specific silencing of MT1-MMP expression suppresses tumor
cell migration and invasion: importance of MT1-MMP as a therapeutic
target for invasive tumors. Oncogene. 22:8716–8722. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakamura H, Ueno H, Yamashita K, et al:
Enhanced production and activation of progelatinase A mediated by
membrane-type 1 matrix metalloproteinase in human papillary thyroid
carcinomas. Cancer Res. 59:467–4573. 1999.PubMed/NCBI
|
|
30
|
Rosenthal EL and Matrisian LM: Matrix
metalloproteases in head and neck cancer. Head Neck. 28:639–648.
2006. View Article : Google Scholar : PubMed/NCBI
|
